Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders

2-oxothiatole compounds having activity as CPLA2 inhibitors for the treatment of inflammatory disorders and hyperproliferative disorders

US Patent 10150781 · Granted Dec 11, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Galactoside inhibitor of galectins2025
Galactoside inhibitor of galectins2024
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2023
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2023
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2023
Combination therapy for proliferative diseases2022
Galactoside inhibitor of galectins2022
Formulation of fat-soluble vitamin2021
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2021
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2021
Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds2021
Combination therapy for proliferative diseases2021